Guardant Health Company Top Insiders
GH Stock | USD 30.98 0.30 0.98% |
Under 84 percent of Guardant Health's insiders are selling. The analysis of insiders' sentiment of trading Guardant Health stock suggests that a large number of insiders are terrified at this time. Guardant Health employs about 1.8 K people. The company is managed by 15 executives with a total tenure of roughly 14 years, averaging almost 0.0 years of service per executive, having 117.87 employees per reported executive.
Helmy Eltoukhy CEO CoCEO CoFounder |
AmirAli Talasaz President President COO, Director |
Guardant Health's Insider Buying Vs Selling
16
Selling | Buying |
Latest Trades
2024-11-13 | Meghan V Joyce | Disposed 2896 @ 29.9 | View | ||
2024-06-04 | Meghan V Joyce | Disposed 100 @ 27.87 | View | ||
2024-03-18 | Kumud Kalia | Acquired 2187 @ 17.82 | View | ||
2024-03-04 | Meghan V Joyce | Disposed 100 @ 19.05 | View | ||
2023-12-04 | Meghan V Joyce | Disposed 100 @ 26.34 | View | ||
2023-12-01 | Kumud Kalia | Disposed 5800 @ 26.37 | View |
Monitoring Guardant Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Guardant |
Guardant Health's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Guardant Health's future performance. Based on our forecasts, it is anticipated that Guardant will maintain a workforce of under 1770 employees by December 2024.Guardant Health Management Team Effectiveness
The company has Return on Asset (ROA) of (0.1608) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1608. This is way below average. Likewise, it shows a return on total equity (ROE) of (6.0928) %, which implies that it produced no returns to current stockholders. Guardant Health's management efficiency ratios could be used to measure how well Guardant Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.28. The current Return On Capital Employed is estimated to decrease to -0.38. As of now, Guardant Health's Intangible Assets are increasing as compared to previous years. The Guardant Health's current Fixed Asset Turnover is estimated to increase to 2.51, while Total Assets are projected to decrease to under 1.4 B.The current Common Stock Shares Outstanding is estimated to decrease to about 92.9 M. The Guardant Health's current Net Loss is estimated to increase to about (559.7 M)
Guardant Health Workforce Comparison
Guardant Health is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 241,627. Guardant Health maintains roughly 1,768 in number of employees contributing less than 1% to equities under Health Care industry.
Guardant Health Profit Margins
The company has Net Profit Margin (PM) of (0.74) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.61) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.61.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.43 | 0.5974 |
|
|
Guardant Health Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Guardant Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Guardant Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Guardant Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 1.1563 | 37 | 32 | 678,179 | 112,465 |
2024-09-01 | 0.6531 | 32 | 49 | 78,742 | 74,400 |
2024-06-01 | 0.8644 | 51 | 59 | 703,754 | 631,630 |
2024-03-01 | 0.7333 | 33 | 45 | 850,106 | 2,330,359 |
2023-12-01 | 1.0294 | 35 | 34 | 354,506 | 57,934 |
2023-09-01 | 0.7143 | 25 | 35 | 283,145 | 30,269 |
2023-06-01 | 1.2105 | 46 | 38 | 353,496 | 193,749 |
2023-03-01 | 1.1579 | 22 | 19 | 211,181 | 27,279 |
2022-12-01 | 1.6667 | 20 | 12 | 324,220 | 5,845 |
2022-09-01 | 1.1667 | 7 | 6 | 172,502 | 13,218 |
2022-06-01 | 0.619 | 13 | 21 | 104,894 | 290,243 |
2022-03-01 | 0.5 | 4 | 8 | 18,110 | 34,158 |
2021-12-01 | 3.2857 | 23 | 7 | 245,325 | 29,604 |
2021-09-01 | 0.9231 | 12 | 13 | 175,417 | 80,035 |
2021-06-01 | 0.2045 | 18 | 88 | 86,086 | 858,232 |
2021-03-01 | 0.0529 | 9 | 170 | 1,149,490 | 3,775,907 |
2020-12-01 | 0.2895 | 11 | 38 | 72,484 | 7,341,725 |
2020-09-01 | 0.225 | 18 | 80 | 351,403 | 1,322,166 |
2020-06-01 | 0.3861 | 39 | 101 | 3,604,883 | 9,881,143 |
2020-03-01 | 0.3684 | 14 | 38 | 108,877 | 402,992 |
2019-12-01 | 0.2857 | 32 | 112 | 344,306 | 1,029,913 |
2019-09-01 | 0.2645 | 41 | 155 | 699,086 | 6,569,444 |
2019-06-01 | 0.2131 | 26 | 122 | 316,133 | 1,401,323 |
2019-03-01 | 2.0 | 2 | 1 | 4,067,980 | 3,000 |
2018-12-01 | 0.717 | 38 | 53 | 62,484,930 | 89,760,664 |
Guardant Health Notable Stakeholders
A Guardant Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Guardant Health often face trade-offs trying to please all of them. Guardant Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Guardant Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Helmy Eltoukhy | CoCEO CoFounder | Profile | |
AmirAli Talasaz | President COO, Director | Profile | |
Jennifer Higgins | Senior Affairs | Profile | |
Stephen Murphy | Senior Marketing | Profile | |
John Saia | Chief Secretary | Profile | |
Christopher Freeman | Chief Officer | Profile | |
John JD | Chief Secretary | Profile | |
Zarak Khurshid | Vice Relations | Profile | |
Terilyn Monroe | Chief Officer | Profile | |
Craig MD | Chief Officer | Profile | |
Andy Ament | VP Operations | Profile | |
Kumud Kalia | Chief Officer | Profile | |
Michael Bell | Chief Officer | Profile | |
Darya Chudova | VP Technology | Profile | |
Darl Moreland | Senior Quality | Profile |
About Guardant Health Management Performance
The success or failure of an entity such as Guardant Health often depends on how effective the management is. Guardant Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Guardant management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Guardant management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.27) | (0.28) | |
Return On Capital Employed | (0.36) | (0.38) | |
Return On Assets | (0.27) | (0.28) | |
Return On Equity | (3.02) | (3.17) |
Guardant Health Workforce Analysis
Traditionally, organizations such as Guardant Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Guardant Health within its industry.Guardant Health Manpower Efficiency
Return on Guardant Health Manpower
Revenue Per Employee | 319K | |
Revenue Per Executive | 37.6M | |
Net Loss Per Employee | 271.2K | |
Net Loss Per Executive | 32M | |
Working Capital Per Employee | 645.5K | |
Working Capital Per Executive | 76.1M |
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |